PB2123 FEASIBILITY, TOLERABILITY AND EFFICACY OF CARFILZOMIB, LENALIDOMIDE AND DESAMETHASONE(KRD) IN RELAPSED REFRACTORY MYELOMA PATIENTS: A REAL-LIFE SURVEY OF THE SICILIAN MYELOMA NETWORK

Authors :: Santo Neri
Renato Scalone
V. Del Fabro
Cinzia Maugeri
Bruno Garibaldi
Ugo Consoli
Giuseppe Mineo
Maurizio Musso
Melania Carlisi
Uros Markovic
Marina Parisi
F. Di Raimondo
Emilia Cotzia
Anxur Merenda
Salvatore Leotta
A. Romano
Valerio Leotta
C. Conticello
Giuseppe Longo
Clotilde Cangialosi
Vanessa Innao
Donato Mannina
Enrica Antonia Martino
Valeria Calafiore
Massimo Poidomani
Giuseppe Sapienza
Source :: HemaSphere. 3:956
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
Carfilzomib
chemistry.chemical_compound
Tolerability
chemistry
Internal medicine
Relapsed refractory
medicine
Desamethasone
business
Lenalidomide
medicine.drug

Full Text Access

Tools